​

Arcellx (ACLX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ACLX Stock Forecast

Arcellx (ACLX) stock forecast, based on 18 Wall Street analysts, predicts a 12-month average price target of $110.42, with a high of $120.00 and a low of $82.00. This represents a -3.39% decline from the last price of $114.29.

$50 $64 $78 $92 $106 $120 High: $120 Avg: $110.42 Low: $82 Last Closed Price: $114.29

ACLX Stock Rating

Arcellx stock's rating consensus is Hold, based on 18 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (38.89%), 11 Hold (61.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 18 11 7 0 Strong Sell Sell Hold Buy Strong Buy

ACLX Price Target Upside V Benchmarks

TypeNameUpside
StockArcellx-3.39%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts101316
Avg Price Target$115.50$110.54$111.50
Last Closing Price$114.29$114.29$114.29
Upside/Downside1.06%-3.28%-2.44%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26--18--18
Feb, 263152--20
Jan, 263152--20
Dec, 253142--19
Nov, 255131--19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 25, 2026Guggenheim$115.00$113.761.09%0.62%
Feb 24, 2026Michael YeeUBS$115.00$113.751.10%0.62%
Feb 24, 2026Market PerformLeerink Partners$115.00$113.751.10%0.62%
Feb 23, 2026Stifel Nicolaus$115.00$113.751.10%0.62%
Feb 23, 2026Cory KasimovEvercore ISI$115.00$113.811.05%0.62%
Feb 23, 2026Emily BodnarH.C. Wainwright$115.00$113.821.04%0.62%
Feb 23, 2026Canaccord Genuity$115.00$113.910.96%0.62%
Feb 23, 2026Wells Fargo$115.00$114.090.80%0.62%
Feb 23, 2026Robert W. Baird$115.00$114.100.79%0.62%
Feb 23, 2026Truist Financial$120.00$114.105.17%5.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 02, 2026Cowen & Co.Holddowngrade
Feb 25, 2026GuggenheimBuyNeutraldowngrade
Feb 24, 2026UBSBuyNeutraldowngrade
Feb 24, 2026CitigroupBuyNeutraldowngrade
Feb 23, 2026H.C. WainwrightBuyNeutraldowngrade
Feb 23, 2026NeedhamBuyHolddowngrade
Feb 23, 2026William BlairMarket Performdowngrade
Jan 07, 2026UBSBuyinitialise
Dec 22, 2025Wells FargoOverweightinitialise
Nov 24, 2025CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-4.28$-1.47$-2.00$-4.07---
Avg Forecast$-5.24$-2.47$-1.61$-2.28$-2.61$-2.29$-0.34
High Forecast$-2.80$-2.11$-1.00$0.88$0.12$0.74$-0.12
Low Forecast$-10.68$-3.00$-2.04$-4.16$-5.29$-5.02$-0.79
Surprise %-18.32%-40.49%24.22%78.51%---

Revenue Forecast

$0 $180M $360M $540M $720M $900M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$110.32M$107.94M----
Avg Forecast$2.14M$67.53M$121.71M$119.48M$183.55M$243.09M$435.02M
High Forecast$3.86M$73.27M$132.76M$198.36M$183.55M$249.62M$882.63M
Low Forecast$1.38M$61.77M$112.49M$61.73M$183.55M$236.55M$220.63M
Surprise %-63.36%-11.32%----

Net Income Forecast

$-550M $-430M $-310M $-190M $-70M $50M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-188.68M$-70.69M$-107.35M$-228.93M---
Avg Forecast$-251.66M$-122.89M$-73.02M$-135.07M$-138.71M$-158.05M$-16.27M
High Forecast$-134.62M$-101.48M$-47.87M$42.07M$5.68M$35.45M$-5.85M
Low Forecast$-513.26M$-144.29M$-98.18M$-200.08M$-254.27M$-241.47M$-38.04M
Surprise %-25.03%-42.48%47.00%69.50%---

ACLX Forecast FAQ

Is Arcellx stock a buy?

Arcellx stock has a consensus rating of Hold, based on 18 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 11 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Arcellx is a neutral investment for most analysts.

What is Arcellx's price target?

Arcellx's price target, set by 18 Wall Street analysts, averages $110.42 over the next 12 months. The price target range spans from $82 at the low end to $120 at the high end, suggesting a potential -3.39% change from the previous closing price of $114.29.

How does Arcellx stock forecast compare to its benchmarks?

Arcellx's stock forecast shows a -3.39% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Arcellx over the past three months?

  • March 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 15.00% Strong Buy, 75.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 15.00% Strong Buy, 75.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.

What is Arcellx’s EPS forecast?

Arcellx's average annual EPS forecast for its fiscal year ending in December 2026 is $-2.61, marking a -35.87% decrease from the reported $-4.07 in 2025. Estimates for the following years are $-2.29 in 2027, and $-0.34 in 2028.

What is Arcellx’s revenue forecast?

Arcellx's average annual revenue forecast for its fiscal year ending in December 2026 is $183.55M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $243.09M, and $435.02M for 2028.

What is Arcellx’s net income forecast?

Arcellx's net income forecast for the fiscal year ending in December 2026 stands at $-139M, representing a -39.41% decrease from the reported $-229M in 2025. Projections indicate $-158M in 2027, and $-16.272M in 2028.